171
Participants
Start Date
September 17, 2024
Primary Completion Date
November 20, 2027
Study Completion Date
July 31, 2030
STX-241
"Film-coated tablet~Route of administration: Oral"
RECRUITING
Universitätsklinikum Carl Gustav Carus Dresden, Dresden
RECRUITING
Vall d'Hebron Institut d'Oncologia, Barcelona
RECRUITING
National Taiwan University Hospital, Taipei
RECRUITING
Taipei Veterans General Hospital, Taipei
RECRUITING
CHU Hôpital de la Timone, Marseille
RECRUITING
Hospital Universitario La Paz, Madrid
RECRUITING
Centro Integral Oncológico Clara Campal (CIOCC), Madrid
RECRUITING
Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse
RECRUITING
Sarah Cannon Research Institute (SCRI) (The SCRI Oncology Research Consortium), Nashville
RECRUITING
Institut de Cancérologie de l'Ouest (ICO) - René Gauducheau, Saint-Herblain
RECRUITING
Centre Léon Bérard, Lyon
RECRUITING
Oncology Consultants (OC) - Texas Medical Center - Cancer Center, Houston
RECRUITING
Gustave Roussy, Villejuif
RECRUITING
Shanghai East Hospital, Tongji University, Shanghai
RECRUITING
Tianjin Medical University Cancer Institute and Hospital, Tianjin
RECRUITING
Netherlands Cancer Institute, Amsterdam
Pierre Fabre Medicament
INDUSTRY